ArticleJAMA internal medicine2021

Prolonged Increases in Public-Payer Spending and Prices After Unapproved Drug Initiative Approval of Colchicine.

Natalie McCormick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.